Endogenous Pain Inhibition Deficiency in Chronic TMD Pain — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Endogenous Pain Inhibition Deficiency in Chronic TMD Pain — Stella

Recruiting

Back to Chronic Temporomandibular Disorders (TMD) trials

Trial locations(1 site)

United States

University of Minnesota, Minneapolis, Minnesota

Key details

Sponsor

University of Minnesota

Enrollment target

~40 participants

Started

September 2024

Primary completion

September 2026

Age range

18 Years – 74 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov